Domů › Akutní lymfoblastická leukemie › New York › New York City
Klinické studie Akutní lymfoblastická leukemie v New York City, NY
23 studií pro Akutní lymfoblastická leukemie hledá účastníky v lokalitách v New York City a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center, New York
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center -- Pediatrics, New York
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
Probíhá náborObservační studie
- Columbia University Medical Center, New York
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Probíhá náborFáze 1/2
- Montefiore Medical Center, New York
Cord Blood Transplant in Adults With Blood Cancers
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center, New York
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center, New York
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Probíhá náborFáze 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of CTD402 in T-ALL/LBL Patients
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Cancer Center, New York
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Probíhá náborFáze 1/2
- Research Site, New York
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Probíhá náborObservační studie
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital at Cornell, New York
- Mount Sinai Medical Center - New York, New York
- a dalších 3
A Study of Revumenib and Mezigdomide in People With Leukemia
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Cancer Center, New York
European Prospective Investigation Into Childhood Cancer
Probíhá náborObservační studie
- Columbia University Irving Medical Center, New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Probíhá náborFáze 2
- Memorial Sloan Kettering, New York
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center, New York
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
Probíhá nábor
- Columbia University Medical Center, New York
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center, New York
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Probíhá náborFáze 1
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
Studie Akutní lymfoblastická leukemie v jiných městech
- Houston, TX28 studií
- Seattle, WA21 studií
- Baldwin Park, CA21 studií
- Chicago, IL20 studií
- Atlanta, GA19 studií
- Memphis, TN16 studií
- Washington, DC16 studií
- Philadelphia, PA16 studií
- Boston, MA15 studií
- Los Angeles, CA14 studií
- Mountain View, CA13 studií
- Durham, NC13 studií
Další studie v New York City
- Rakovina prsu136 studií
- Nemalobuněčný plicní karcinom121 studií
- Rakovina (všechny typy)109 studií
- Rakovina prostaty103 studií
- Metastatický karcinom93 studií
- Kolorektální karcinom78 studií
- Rakovina vaječníků69 studií
- Rakovina plic60 studií
- Mnohočetný myelom60 studií
- Rakovina slinivky břišní60 studií
- Rakovina endometria52 studií
- Akutní myeloidní leukemie51 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.